SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-10-067006
Filing Date
2010-03-25
Accepted
2010-03-25 14:46:07
Documents
11
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 460401
2 CONSULTING AGREEMENT dex106.htm EX-10.6 36456
3 EMPLOYMENT LETTER dex107.htm EX-10.7 8425
4 AMENDMENT #2 TO OFFICE LEASE dex1010.htm EX-10.10 12510
5 2009 EQUITY INCENTIVE PLAN dex1017.htm EX-10.17 143439
6 CONSENT OF MAYER HOFFMAN MCCANN PC dex231.htm EX-23.1 1402
7 CERTIFICATION dex311.htm EX-31.1 9483
8 CERTIFICATION dex312.htm EX-31.2 9468
9 CERTIFICATION dex321.htm EX-32.1 5271
10 GRAPHIC g85459ex10_7pg1.jpg GRAPHIC 15916
11 GRAPHIC g85459g31e15.jpg GRAPHIC 44473
  Complete submission text file 0001193125-10-067006.txt   771893
Mailing Address 6042 CORNERSTONE CT. WEST SUITE B SAN DIEGO CA 92121
Business Address 6042 CORNERSTONE CT. WEST SUITE B SAN DIEGO CA 92121 858-210-3700
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-52228 | Film No.: 10704323
SIC: 6770 Blank Checks